Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Oncology Division Revenues [legacy 2023–2024 tag] by Quarter
Oncology Division Revenues [legacy 2023–2024 tag] ($M) ($M)
Pfizer Oncology Division Revenues [legacy 2023–2024 tag]: $3,051M in Q4 2024, up 39.3% from a year earlier. That is the highest of the 8 quarters on record here. No newer figure appears in the documents we track.
Where the Q4 2024 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2025-02-27) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Oncology Division Revenues [legacy 2023–2024 tag] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2024 | Dec 31, 2024 | 3,051 | +39.3% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 29, 2024 | 3,026 | +43.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,918 | +34.7% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,572 | +29.7% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 2,190 | – | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 2,111 | – | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 2,167 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 1,983 | – | Form 10-Q (filed 2024-05-08) ↗ |
Cite this data
StockData. (2026). Pfizer Oncology Division Revenues [legacy 2023–2024 tag] ($M), quarterly Q1 2023–Q4 2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/div-leg-onc-div
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.